Carisma Therapeutics
CARM
CARM
53 hedge funds and large institutions have $9.28M invested in Carisma Therapeutics in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 20 closing their positions.
Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
22
Increased
7
Reduced
16
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$354K |
| 2 |
2
Millennium Management
New York
|
$243K |
| 3 |
3
Jane Street
New York
|
$243K |
| 4 |
YIH
4
Y-Intercept (HK)
Hong Kong
|
$115K |
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$111K |
